Daily8d
FDA approves new oral treatment for uncomplicated UTI in adult women
The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...
Medpage Today on MSN12d
FDA Approves Novel Treatment for UTIs
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...
Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...
BioSpace9d
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman ...
infectiousdiseaseadvisor.com2d
Orlynvah Approved for Uncomplicated UTI in Women With Limited Treatment Options
FDA approved Orlynvah for the Tx of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis.
FiercePharma12d
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...